Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05646485 · ClinicalTrials.gov registry record · NA
Bladder Cancer Screening Trial
A NA study of Smoking Cessation and Bladder Cancer, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 1
- Study location
NCT05646485 is a NA study of Smoking Cessation and Bladder Cancer that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 1,000 participants, above the 469-participant average among 188 other Smoking Cessation trials with a reported enrollment target (113% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05646485, a NA study of Smoking Cessation and Bladder Cancer, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
There is currently no accepted screening strategy for patients at high risk of developing bladder cancer. This study will ask patients to complete a urine test every 6 months for 2 years to help assess if routine screening helps finding bladder cancer at an earlier stage.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Urinalysis
Study Locations (1)
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2023-05-05 |
| Est. Completion | 2028-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05646485
The ClinicalTrials.gov registry entry for NCT05646485 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 469-participant average among 188 other Smoking Cessation trials with a reported enrollment target (113% higher). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which Urinalysis is the first listed.
NCT05646485 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05646485 about?
NCT05646485 is a clinical study titled "Bladder Cancer Screening Trial". There is currently no accepted screening strategy for patients at high risk of developing bladder cancer. This study will ask patients to complete a urine test every 6 months for 2 years to help assess if routine screening helps finding bladder cancer at an earlier stage.
What is the current status of trial NCT05646485?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2023-05-05. Estimated completion is 2028-04.
What conditions does trial NCT05646485 study?
This clinical trial studies the following conditions: Smoking Cessation, Bladder Cancer, Urothelial Carcinoma, Hematuria.
What interventions are being tested in trial NCT05646485?
The interventions under investigation include: Urinalysis (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05646485?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05646485 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.